Significant improvement for clinical cancer research in Germany

AcademicLabs Partners with BioRN Community to Identify Regional Collaborators and Boost Visibility

BioMed X and AbbVie Extend Research Collaboration in the US

Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power

Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03

Protecting the next generations with vaccines

Heidelberg / Mannheim University Hospital Link-Up: Reviewed and Rapid Implementation Recommended

Genomic Data Infrastructure – integrating genomics into healthcare

Open Targets consortium welcomes Genentech as newest member

Heidelberg Pharma’s Partner Telix Reports Positive Data on the Pivotal ZIRCON Study

Affimed and Artiva Biotherapeutics Announce Partnership

BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development

Analysis of genetic changes in rare cancers

Apogenix’ Asunercept Demonstrates Efficacy in Phase II Trial

Collaboration with MLL on AI-based Karyotyping

Greener Chemistry with Flow Chemistry at Raybow PharmaScience

REPO4EU’s Euro / Global Platform for Drug Repurposing

ERC Proof-of-Concept grant provides way to realise commercial potential of ‘SpaceM’ technology

Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda

EVI's new publication identifies gaps in outreach information on COVID-19 vaccine trials in Europe